TrialBritish journal of clinical pharmacology2012

Mechanism-based population modelling of the effects of vildagliptin on GLP-1, glucose and insulin in patients with type 2 diabetes.

Cornelia B Landersdorfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.